THE BEST SIDE OF ABBV-744 CLINICAL TRIAL PHASE 1 RESULTS

Supplemental studies in progress counsel that ARV-825 may additionally be effective in improving the response to estrogen deprivation (aromatase inhibition), another component of ordinary of treatment in ER+ breast cancer.There might be greater treatment stress for participants During this trial as compared to their normal of treatment. Participant